| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |